DOJ (US Department of Justice) looks into Guidant's AAA product issues
This article was originally published in Clinica
Executive Summary
The US Department of Justice and the FDA's Office of Criminal Investigations have begun a criminal inquiry concerning Guidant's Ancure endograft system for the treatment of abdominal aortic aneurysms (AAA).